Analysis of risk evaluation and mitigation strategies for teratogenic drugs: Variation in primary and secondary prevention measures

In an analysis of risk evaluation and mitigation strategies for teratogenic drugs, Ameet Sarpatwari, Beatrice Brown and Aaron Kesselheim explore the variation in primary and secondary prevention measures.

Detalles Bibliográficos
Autores principales: Brown, Beatrice L., Kesselheim, Aaron S., Sarpatwari, Ameet
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2023
Materias:
Policy Forum
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9987786/
https://www.ncbi.nlm.nih.gov/pubmed/36877723
http://dx.doi.org/10.1371/journal.pmed.1004190
_version_ 1784901450557554688
author Brown, Beatrice L.
Kesselheim, Aaron S.
Sarpatwari, Ameet
author_facet Brown, Beatrice L.
Kesselheim, Aaron S.
Sarpatwari, Ameet
author_sort Brown, Beatrice L.
collection PubMed
description In an analysis of risk evaluation and mitigation strategies for teratogenic drugs, Ameet Sarpatwari, Beatrice Brown and Aaron Kesselheim explore the variation in primary and secondary prevention measures.
format Online
Article
Text
id pubmed-9987786
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-99877862023-03-07 Analysis of risk evaluation and mitigation strategies for teratogenic drugs: Variation in primary and secondary prevention measures Brown, Beatrice L. Kesselheim, Aaron S. Sarpatwari, Ameet PLoS Med Policy Forum In an analysis of risk evaluation and mitigation strategies for teratogenic drugs, Ameet Sarpatwari, Beatrice Brown and Aaron Kesselheim explore the variation in primary and secondary prevention measures. Public Library of Science 2023-03-06 /pmc/articles/PMC9987786/ /pubmed/36877723 http://dx.doi.org/10.1371/journal.pmed.1004190 Text en © 2023 Brown et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Policy Forum
Brown, Beatrice L.
Kesselheim, Aaron S.
Sarpatwari, Ameet
Analysis of risk evaluation and mitigation strategies for teratogenic drugs: Variation in primary and secondary prevention measures
title Analysis of risk evaluation and mitigation strategies for teratogenic drugs: Variation in primary and secondary prevention measures
title_full Analysis of risk evaluation and mitigation strategies for teratogenic drugs: Variation in primary and secondary prevention measures
title_fullStr Analysis of risk evaluation and mitigation strategies for teratogenic drugs: Variation in primary and secondary prevention measures
title_full_unstemmed Analysis of risk evaluation and mitigation strategies for teratogenic drugs: Variation in primary and secondary prevention measures
title_short Analysis of risk evaluation and mitigation strategies for teratogenic drugs: Variation in primary and secondary prevention measures
title_sort analysis of risk evaluation and mitigation strategies for teratogenic drugs: variation in primary and secondary prevention measures
topic Policy Forum
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9987786/
https://www.ncbi.nlm.nih.gov/pubmed/36877723
http://dx.doi.org/10.1371/journal.pmed.1004190
work_keys_str_mv AT brownbeatricel analysisofriskevaluationandmitigationstrategiesforteratogenicdrugsvariationinprimaryandsecondarypreventionmeasures
AT kesselheimaarons analysisofriskevaluationandmitigationstrategiesforteratogenicdrugsvariationinprimaryandsecondarypreventionmeasures
AT sarpatwariameet analysisofriskevaluationandmitigationstrategiesforteratogenicdrugsvariationinprimaryandsecondarypreventionmeasures

Ejemplares similares